Publication of data for SYNB1020 a potential treatment for hyperammonemia
SYNB1020, Synlogic's Synthetic Biotic medicine, demonstrates safety and proof of mechanism in healthy volunteers, clearing ammonia from the blood. The therapy is being evaluated in patients with cirrhosis and elevated blood ammonia, offering a potential new treatment for hyperammonemia.